Skip to search formSkip to main contentSkip to account menu

Mixed cryoglobulinemia

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Abstract Background and aim: Mixed cryoglobulinemia (MC) has been associated with several viral infections, and chronic hepatitis… 
Highly Cited
2010
Highly Cited
2010
This study illustrates the use and efficacy of a combination of pegylated interferon-alpha (Peg-IFN-alpha) and ribavirin (RBV… 
Highly Cited
2008
Highly Cited
2008
Rituximab, an anti-CD20 monoclonal antibody, has been used to treat autoimmune disorders such as mixed cryoglobulinemia (MC… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND Data on essential mixed cryoglobulinemia (MC) are scarce, and most date back to studies before 1989 (ie, before the… 
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To assess the benefit of interferon-alpha/ribavirin combination therapy in hepatitis C virus (HCV) infected patients… 
Highly Cited
1998
Highly Cited
1998
Clonal rearrangements of Ig heavy chain (IgH) genes and hepatitis C virus (HCV) genomic sequences were assayed on intrahepatic B… 
Highly Cited
1995
Highly Cited
1995
Hepatitis C virus (HCV) has been implicated as the major etiologic factor sustaining B-cell clonal expansion in type II mixed… 
Highly Cited
1994
Highly Cited
1994
Type II mixed cryoglobulinemia (MC) is an often progressive vasculitis characterized by circulating cold-precipitable proteins… 
Highly Cited
1993
Highly Cited
1993
The effects of interferon-alpha (IFN-alpha) on clinical and serologic manifestations of mixed cryoglobulinemia (MC) were…